Details for New Drug Application (NDA): 205441
✉ Email this page to a colleague
NDA 205441 describes TRI-MILI, which is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA. It is available from three suppliers. Additional details are available on the TRI-MILI profile page.
The generic ingredient in TRI-MILI is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
The generic ingredient in TRI-MILI is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
Summary for 205441
| Tradename: | TRI-MILI |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | ethinyl estradiol; norgestimate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 205441
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRI-MILI | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 205441 | ANDA | Afaxys Pharma, LLC | 50102-233 | 50102-233-11 | 1 BLISTER PACK in 1 CARTON (50102-233-11) / 1 KIT in 1 BLISTER PACK |
| TRI-MILI | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 205441 | ANDA | Afaxys Pharma, LLC | 50102-233 | 50102-233-13 | 3 BLISTER PACK in 1 CARTON (50102-233-13) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG | ||||
| Approval Date: | Jul 6, 2016 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
